BlackRock Health Sciences:BME

    Manage Alerts

    Overview

    As of 1/22/2025

     Share
    Price
    NAVPremium/
    Discount
    Current$39.97$42.58-6.14%
    52 Wk Avg$40.57$43.84-7.43%
    52 Wk High$42.75$46.00-2.35%
    52 Wk Low$36.87$40.83-10.28%
    Regular Distribution TypeManaged Distribution
    Distribution Rate7.87%
    Distribution Amount$0.2621
    Distribution FrequencyMonthly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    The Trust’s investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.

    Capital Structure

    As of 1/22/2025

    Total Investment Exposure:$564.419M
    Total Common Assets:$564.419M
    Common Shares Outstanding:13,255,490
    Leverage

    As of 6/28/2024

    Preferred Share Assets:
    Total Debt (USD): $0.061M
    Regulatory Leverage (USD): $0.061M
    Effective Leverage (USD): $0.061M
    Effective Leverage (%): 0.01%
    Annual Expense Ratios

    As of 12/31/2024

      Per Common Share
    Management FeesN/A
    Other Expenses:N/A
    Baseline Expense: N/A
    Interest Expense:N/A
    Total: 1.06%
    Fund Management

    Fund Sponsor
    BlackRock

    Portfolio Managers
    Christopher M. Accettella, Xiang Liu, Erin Xie, Kyle McClements

    Basics
    Category: Equity-Sector Equity
    Ticker: BME
    NAV Ticker: XBMEX
    Average Daily Volume (shares): 38,250
    Average Daily Volume (USD): $1.536M
    Inception Date: 3/28/2005
    Inception Share Price: $25.00
    Inception NAV: $23.83
    Tender Offer: No
    Term: No
    Fiscal Year End: December 31
    Third Party Links & Reports

    Distributions

    As of 1/22/2025

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 6/30/2024
    $0.0616
    Annualized Distribution Rate on NAV:
    As of 1/22/2025
    7.39%
    Total Return on NAV (12 months):
    As of 1/22/2025
    3.67%
    Total % Portfolio Effectively Leveraged:
    As of 1/22/2025
    0.01%

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 1/22/2025

    PeriodAvg Discount
    6 Month-7.86%
    1 Year-7.43%
    3 Year-3.54%
    5 Year-1.30%
    Z-Score

    As of 1/22/2025

    PeriodZStat
    3 Month2.12
    6 Month2.24
    1 Year0.85
    Pricing History
    Date NAV Premium / Discount

    Performance

    Calendar Year Total Returns

    As of 12/31/2024
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    YTD-0.05%3.67%28.60%12.57%
    2024-0.05%3.67%28.60%12.57%
    2023-1.09%3.52%4.81%6.23%
    2022-4.56%-4.13%-10.73%-7.15%
    20217.35%10.66%22.39%17.58%
    202018.69%17.48%5.15%5.71%
    201924.23%22.38%26.64%22.38%
    20186.53%7.19%-12.35%-9.96%
    201723.28%22.30%18.18%12.88%
    2016-11.75%-5.18%17.45%14.67%
    20158.53%11.21%-15.98%-12.75%
    201434.00%25.26%5.16%4.65%
    201340.35%36.38%16.34%17.44%
    201221.45%17.79%  
    20115.50%5.07%  
    20106.41%4.51%  
    200941.81%26.73%  
    2008-20.74%-16.74%  
    20078.07%18.00%  
    200617.64%8.85%  
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 12/31/2024
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Number of Holdings:
    As of 9/30/2024
    139
    Annual Portfolio Turnover:
    As of 12/31/2024
    43.00%
    Asset Allocation

    As of 9/30/2024

    Top Sectors

    As of 9/30/2024

    Sector%Portfolio
    Defensive (Super Sector)99.49%
    Healthcare99.49%
    Cash Equivalents0.73%
    Cash Equivalents (Super Sector)0.73%
    Financial Services0.10%
    Cyclical (Super Sector)0.10%
    Future Forward0.00%
    Derivative (Super Sector)0.00%
    Top Holdings

    As of 9/30/2024

    HoldingValue% Portfolio
    UnitedHealth Group Inc$58.78M9.57%
    Eli Lilly and Co$58.16M9.47%
    Boston Scientific Corp$37.08M6.04%
    Amgen Inc$24.29M3.96%
    Intuitive Surgical Inc$22.59M3.68%
    Danaher Corp$21.69M3.53%
    AbbVie Inc$21.64M3.52%
    Thermo Fisher Scientific Inc$18.76M3.05%
    Elevance Health Inc$17.82M2.90%
    Stryker Corp$17.64M2.87%
    Country Allocation

    As of 9/30/2024

    Country% Portfolio
    United States - Equity95.39%
    United Kingdom - Equity0.86%
    France - Equity0.83%
    Denmark - Equity0.79%
    Switzerland - Equity0.64%
    China - Equity0.24%
    Canada - Equity0.23%
    Germany - Equity0.19%
    Netherlands - Equity0.18%
    Japan - Equity0.18%
    Belgium - Equity0.05%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.

    NOTES:

    Distribution type sourced from Morningstar. In general, managed distributions may be sourced from net investment income, realized gains and return of capital. CEFConnect.com does not undertake to disclose specific information about closed-end fund distribution sources. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.

    E-2949862P-E0623W